Invited by the organizing commission of Bio Partnering APAC 2017,Dr.Huang Yanshan, CEO of Doer Biologics, attended the summit meeting and gave a speech “Developing Innovative Multi-domain Therapeutical Proteins”, introducing Doer self-developed xLONGylation®, MultiBody® and AccuBody® platforms and a series of new developing drugs with these platforms.